Kin-Ming Lo - Concepedia

Author

Kin-Ming Lo

Harvard University ORCID

Also Known As

K M Lo, K. M. Lo, K.-M. Lo, K.M. Lo, KIN-MING LO, Kin-Ming Lo, Kin‐Ming Lo, Lo, K. M., Lo, K.M., Rachel Salazar

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Harvard University Lexicon Pharmaceuticals (United States)Ono Pharmaceutical (United States)Merck Serono (Italy)Merck (Germany)

About

Kin-Ming Lo is an author at Harvard University specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.9K
2	Natural Sciences	6	6	432
3	Engineering	1	1	157
4	Health Sciences	1	1	13
5	Allergy	1	1	55

Kin-Ming Lo

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice Gabriele Bergers, Kashi Javaherian, Kin-Ming Lo, Science Tumor BiologyAngiogenesisOncologyAngiogenesis InhibitorsSolid Tumors	1999	987
Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Karen S. Moulton, Khashayar Vakili, David Zurakowski, Proceedings of the National Academy of Sciences	2003	650
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β Yan Lan, Dong Zhang, Chunxiao Xu, Science Translational Medicine	2018	474
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies† Jonathan H. Davis, Christel Aperlo, Yue Li, Protein Engineering Design and Selection	2010	185
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion Yan Lan, Mahmoud Moustafa, Maximilian Knoll, Cancer Cell	2021	178
Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Stephen D. Gillies, Edward B. Reilly, Kin-Ming Lo, Proceedings of the National Academy of Sciences ImmunologyImmunologic MechanismImmunotherapeuticsImmunotherapyIl2 Activity	1992	177
Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codons Kin-Ming Lo, Simon S. Jones, Neil R. Hackett, Proceedings of the National Academy of Sciences EngineeringBacteriophageMolecular BiologySynthetic Dna DuplexesEnzymatic Modification	1984	157
Zinc-dependent dimers observed in crystals of human endostatin Yuanhua Ding, Kashi Javaherian, Kin-Ming Lo, Proceedings of the National Academy of Sciences Zinc-dependent DimersCrystal StructureZinc-binding SiteBiochemistryBiomedical Research	1998	131
Oligomerization-Dependent Regulation of Motility and Morphogenesis by the Collagen Xviii Nc1/Endostatin Domain Calvin J. Kuo, Kenneth R. LaMontagne, Guillermo García‐Cardeña, The Journal of Cell Biology	2001	114
A Low-Toxicity IL-2–Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity Stephen D. Gillies, Yan Lan, Thore Hettmann, Clinical Cancer Research	2011	95

Page 1